Predicting EQ-5D values using the SGRQ

Value in Health

Volumn 14, Issue 2, 2011, Pages 354-360

  Starkie, Helen J ^a   Briggs, Andrew H ^b   Chambers, Mike G ^c   Jones, Paul ^d  

^a NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c GLAXOSMITHKLINE   (United Kingdom)

^d ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

EQ 5D; Mapping; Quality adjusted life years; Questionnaire; St. George's Respiratory; Utility

Indexed keywords

FLUTICASONE; PLACEBO; SALMETEROL;

ADULT; ALGORITHM; ARTICLE; BIOMEDICAL TECHNOLOGY ASSESSMENT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; DISEASE SEVERITY; DRUG EFFICACY; EQ 5D; FEMALE; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PREDICTION; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; QUESTIONNAIRE; SAINT GEORGE RESPIRATORY QUESTIONNAIRE; SCORING SYSTEM; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; VALIDATION STUDY;

EID: 79959586428     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1016/j.jval.2010.09.011     Document Type: Article

References (21)

1. National Institute for Health and Clinical Excellence. Guide to the methods of technology appraisal. London, 2008. London, National Institute for Health and Clinical Excellence.
2. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A selfcomplete measure of health status for chronic airflow limitation. Am Rev Respir Dis 1992;145:1321-7.
3. Wu E, Mulani P, Farrell MH, Sleep D. Mapping FACT-P and EORTC QLQ-C30 to patient health status measured by EQ-5D metastatic hormone-refractory prostate cancer patients. Value Health 2007;10:408-14. (Pubitemid 47481112)
4. Buxton MJ, Lacey LA, Feagan BG, et al. Mapping from disease-specific measures to utility: An analysis of the relationships between the inflammatory bowel disease questionnaire and Crohn's disease activity index in Crohn's disease and measures of utility. Value Health 2007;10:214-20. (Pubitemid 46802279)
5. Barton G, Sach TH, Jenkinson C, et al. Do estimates of costutility based on the EQ-5D differ from those based on the mapping of utility scores? Health Qual Life Outcomes 2008;6: 51.
6. Brennan DS, Spencer AJ. Mapping oral health related quality of life to generic health state values. BMC Health Serv Res 2006;6:96.
7. Longworth L, Buxton MJ, Sculpher M, Smith DH. Estimating utility data from clinical indicators for patients with stable angina. Eur J Health Econ 2005;6:347-53. (Pubitemid 41779933)
8. Tsuchiya A, Brazier J, McColl E, Parkin D. Deriving preference-based single indices from non-preference based condition-specific instruments: Converting AQLQ into EQ-5D indices. Sheffield Health Economics Group discussion paper, University of Sheffield, Sheffield, UK. 2002.
9. Sauerland S, Weiner S, Dolezalova K, et al. Mapping utility scores from a disease specific quality of life measure in bariatric surgery patients. Value Health 2009;12:364-70.
10. Calverley PM, Anderson JA, Celli B, et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007;356:775-89. (Pubitemid 46294610)
11. GOLD. Global Initiative for Chronic Obstructive Lung Disease: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (updated 2009). Available from: Www.goldcopd.com. [Accessed January 14, 2011].
12. Manning WG, Mullaly J. Estimating log models: To transform or not to transform? J Health Econ 2001;20:461-94. (Pubitemid 32515166)
13. Pearson ES, Please NW. Relationship between the shape of population distribution and the robustness of four simple test statistics. Biometrika 1975;62:223-41.
14. Pregibon D. Goodness of link tests for generalized linear models. Appl Stat 1980;29:24.
15. Hosmer DW, Lemeshow S, Applied Logistic Regression, 2nd ed. New York: John Wiley & Sons, Inc., 2000.
16. Glick HA, Doshi JA, Sonnad SS, Polsky D. Economic Evaluation in Clinical Trials. New York: Oxford University Press Inc., 2007.
17. Lachenbruch PA. Analysis of data with excess zeros. Stat Methods Med Res 2002;11:297-302.
18. Lipscomb J, Ancukiewicz M, Parmigiani G, et al. A comparison of alternative models applied to stroke. Med Decis Making 1998;18(Suppl. 2):S39-66.
19. Brazier J, Yang Y, Tsuchiya A, Rowen D. A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures. Eur J Health Econ 2010;11:215-25.
20. McKenzie L, van der Pol M. Mapping the EORTC QLQ C-30 onto the EQ-5D instrument: The potential to estimate QALYs without generic preference data. Value Health 2009;12:167-71.
21. Blough DK, Ramsey S, Sullivan SD, Yusen R. The impact of using different imputational methods for missing quality of life scores on the estimation of the cost effectiveness of lung volume reduction surgery. Health Econ 2009;18:91-101.